INS and chronic lung disease: Regarding pre-existing comorbidities potentially associated with poor prognosis for COVID-19 disease, chronic lung diseases were the most prevalent (8.2%), followed by hypertension (6.2%), obesity (5.0%), diabetes (2.4%, with 0.6% of patients reporting insulin use) and heart disease (2.2%).